查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
發作性睡病治療市場，按類型、產品、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1419095

發作性睡病治療市場，按類型、產品、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Narcolepsy Therapeutics Market, By Type, By Product, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年，發作性睡病治療市場規模為 34.3 億美元，2023 年至 2030 年複合CAGR為 8.34%。

發作性睡病治療市場-市場動態

睡眠障礙盛行率的增加、研發活動和投資的增加將推動市場需求

研發支出和活動的增加、疾病盛行率的上升以及創新藥品的推出是推動市場擴張的一些主要原因。根據美國國家神經疾病和中風研究所 (NINDS) 的估計，發作性睡病影響美國 135,000 至 20 萬人。在未來幾年中，被診斷為發作性睡病的人數可能會增加，因為這種疾病在承受較高壓力的人中更為常見。在預測期內，推動市場擴張的關鍵驅動力之一是患者基礎的增加。根據國家罕見疾病組織的數據，大約每 2,000 人中就有 1 人患有這種疾病。同樣，美國神經病學會的研究發現，每 10 萬人中患病率從 20 到 60 不等。

由於為治療疾病引入新的治療解決方案的研發 (R&D) 努力不斷增加，該市場不斷成長。由於最近研究和開發活動的加速，新的治療替代方案將在未來幾年推出。例如，2021年5月，武田藥品工業株式會社宣布研發針對發作性睡病的藥物。

發作性睡病治療市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球市場在預測期內（2023-2030 年）每年將以 8.34% 左右的CAGR成長
  • 根據類型細分，由於 WAKIX、Xyrem、Xywav 等新型藥物的廣泛採用，預計猝倒症細分市場將在 2022 年顯示最大的市場佔有率。
  • 根據產品細分，羥丁酸鈉是 2022 年的領先細分市場，主要是由於診斷意識程度不斷提高。
  • 從地區來看，北美是 2022 年的主要收入來源。亞太地區預計在預測期內以最快的 CAGE 成長。

發作性睡病治療市場區隔分析：

全球發作性睡病治療市場根據類型、產品和地區進行細分。

市場依類型分為兩類：猝倒型和無猝倒型。猝倒症細分市場佔據主導地位。作為患者主要症狀的猝倒盛行率的上升正在推動該細分市場的成長。

市場依產品分為三類：中樞神經系統興奮劑、羥丁酸鈉和三環抗憂鬱劑。氧丁酸鈉細分市場在市場上佔據主導地位，並可能在預測期內保持其主導地位。預計針對罕見神經系統疾病患者的中樞神經系統興奮劑的研發工作不斷增加將推動該領域的成長。

發作性睡病治療市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

發作性睡病治療市場-競爭格局：

發作性睡病治療市場本質上較不分散，很少有參與者主導全球市場。市場主要參與者專注於新產品設計以及快速投資和併購。例如，2022年5月，Axsome Therapeutics, Inc.宣佈在美國市場從Jazz Pharmaceuticals收購Sunosi。

最近的發展：

2023 年 5 月，Avadel Pharmaceuticals 的治療發作性睡病藥物 Lumryz 獲得美國 FDA 最終批准。

2022 年 1 月，美國 FDA 核准 Jazz Pharmaceuticals 的 Xywav 取得孤兒藥獨佔權，用於治療成人特發性嗜睡症。

目錄

第1章：發作性睡病治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 發作性睡病治療市場片段（按類型）
    • 發作性睡病治療市場片段（按產品）
    • 發作性睡病治療市場片段（按國家/地區）
    • 按地區分類的發作性睡病治療市場片段
  • 競爭洞察

第 3 章：發作性睡病治療主要市場趨勢

  • 發作性睡病治療市場促進因素
    • 市場促進因素的影響分析
  • 發作性睡病治療市場限制
    • 市場限制影響分析
  • 發作性睡病治療市場機會
  • 發作性睡病治療市場未來趨勢

第 4 章：發作性睡病治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：發作性睡病治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：發作性睡病治療市場格局

  • 2022 年發作性睡病治療市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：嗜睡症治療市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 猝倒症
    • 沒有猝倒

第 8 章：嗜睡症治療市場 - 副產品

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 中樞神經系統興奮劑
    • 羥丁酸鈉
    • 三環抗憂鬱劑。

第 9 章：發作性睡病治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美發作性睡病治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按產品）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲發作性睡病治療藥物主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按產品）
    • 德國
    • 義大利
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區發作性睡病治療藥物主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按產品）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲發作性睡病治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按產品）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲發作性睡病治療藥物主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按產品）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章：主要供應商分析 - 嗜睡症治療產業

  • 競爭儀表板
  • 公司簡介
    • Teva Pharmaceutical Industries Ltd.
    • Avadel Pharmaceuticals
    • Jazz Pharmaceuticals, Inc.
    • Takeda Pharmaceutical Company
    • Harmony Biosciences
    • Novartis AG
    • Rhodes Pharmaceuticals LP
    • Axsome Therapeutics, Inc.
    • Janssen Global Services, LLC
    • Ligand Pharmaceuticals Incorporated
    • Shionogi Inc.
    • Eli Lilly and Company
    • Others

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2160

REPORT HIGHLIGHT

Narcolepsy Therapeutics Market size was valued at USD 3,430 Million in 2022, expanding at a CAGR of 8.34% from 2023 to 2030.

A lifelong sleep illness that causes uncontrollably sudden episodes of extreme sleepiness called as narcolepsy which impacts all facets of a patient's life and makes daily tasks challenging. Narcolepsy can be treated symptomatically with medications that promote wakefulness and raise dopamine release at the presynaptic level.

Narcolepsy Therapeutics Market- Market Dynamics

Increasing prevalence of sleep disorder, increasing R&D activities & investments is to propel market demand

Increasing R&D expenditures and activities, rising disease prevalence, and the launch of innovative medicinal goods are some of the main causes propelling market expansion. Narcolepsy affects between 135,000 and 200,000 people in the United States, according to estimates from the National Institute of Neurological Disorders and Stroke (NINDS). In the upcoming years, there will likely be a rise in the number of people with narcolepsy diagnoses because the disease is more common in those who experience higher levels of stress. Over the forecast period, one of the key drivers propelling the market expansion is an increase in the patient base. As per the National Organization for Rare Disorders, around 1 in 2,000 individuals are affected with the condition. In a similar vein, the American Academy of Neurology study found that the prevalence of disease varies from 20 to 60 in 100,000 people.

The market is growing because of an increase in research and development (R&D) efforts to introduce novel therapeutic solutions for the treatment of disease. New treatment alternatives will be introduced in the upcoming years because of the recent acceleration of research and development activity. For example, in May 2021, Takeda Pharmaceutical Company Limited announced that research and development for narcolepsy medication.

Narcolepsy Therapeutics Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.34% over the forecast period (2023-2030)
  • Based on Type segmentation, cataplexy segment was predicted to show maximum market share in the year 2022, owing to its high adoption of novel drugs such as WAKIX, Xyrem, Xywav, etc.
  • Based on Product segmentation, sodium oxybate was the leading segment in 2022, mainly due to growing awareness levels pertaining to diagnosis.
  • On the basis of region, North America was the leading revenue generator in 2022. Asia Pacific expected to grow at the fastest CAGE over the forecast period.

Narcolepsy Therapeutics Market- Segmentation Analysis:

The Global Narcolepsy Therapeutics Market is segmented on the basis of Type, Product, and Region.

The market is divided into two categories based on Type: cataplexy and without cataplexy. The cataplexy segment dominates the market. The rise in a prevalence of cataplexy as a major symptom in patients is boosting the segment growth.

The market is divided into three categories based on Product: Central Nervous System Stimulants, Sodium Oxybate, and Tricyclic Antidepressants. The Sodium Oxybate segment dominates the market and is likely to maintain its dominance during the forecast period. It is anticipated that rising R&D efforts pertaining to CNS stimulants for patients with uncommon neurological illnesses will drive the segment's growth.

Narcolepsy Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Narcolepsy Therapeutics Market- Competitive Landscape:

The Narcolepsy Therapeutics market is less fragmented in nature with few players dominating global market. Key players in the market are focused on new product design paired with the rapid investment and mergers & acquisitions. For example, in May 2022, Axsome Therapeutics, Inc. announced the attainment of Sunosi from Jazz Pharmaceuticals across U.S. market.

Recent Developments:

In May 2023, Avadel Pharmaceuticals received final U.S. FDA approval for its drug Lumryz for the treatment of narcolepsy.

In January 2022, the U.S. FDA approved Orphan Drug Exclusivity for Jazz Pharmaceuticals' Xywav for the treatment of idiopathic hypersomnia in adults.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NARCOLEPSY THERAPEUTICS MARKET KEY PLAYERS

  • Teva Pharmaceutical Industries Ltd.
  • Avadel Pharmaceuticals
  • Jazz Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company
  • Harmony Biosciences
  • Novartis AG
  • Rhodes Pharmaceuticals L.P.
  • Axsome Therapeutics, Inc.
  • Janssen Global Services, LLC
  • Ligand Pharmaceuticals Incorporated
  • Shionogi Inc.
  • Eli Lilly and Company
  • Others

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY TYPE

  • Cataplexy
  • Without Cataplexy

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY PRODUCT

  • Central Nervous System Stimulants
  • Sodium Oxybate
  • Tricyclic Antidepressants

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Narcolepsy Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Narcolepsy Therapeutics Market Snippet by Type
    • 2.1.2. Narcolepsy Therapeutics Market Snippet by Product
    • 2.1.3. Narcolepsy Therapeutics Market Snippet by Country
    • 2.1.4. Narcolepsy Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Narcolepsy Therapeutics Key Market Trends

  • 3.1. Narcolepsy Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Narcolepsy Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Narcolepsy Therapeutics Market Opportunities
  • 3.4. Narcolepsy Therapeutics Market Future Trends

4. Narcolepsy Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Narcolepsy Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Narcolepsy Therapeutics Market Landscape

  • 6.1. Narcolepsy Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Narcolepsy Therapeutics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Cataplexy
    • 7.1.3. Without Cataplexy

8. Narcolepsy Therapeutics Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 8.1.2. Central Nervous System Stimulants
    • 8.1.3. Sodium Oxybate
    • 8.1.4. Tricyclic Antidepressants.

9. Narcolepsy Therapeutics Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Narcolepsy Therapeutics Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Narcolepsy Therapeutics Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.7.5. Overview
      • 9.3.7.6. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.7. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.7.8. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.8. France
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.8.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.9. Russia
      • 9.3.9.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.9.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.10. Netherlands
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.10.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.11. Sweden
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.12. Poland
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.12.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.13. Rest of Europe
      • 9.3.13.1. Overview
      • 9.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.13.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.13.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Narcolepsy Therapeutics Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.6.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.7.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.8.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.9.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.10.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.11.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.12.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.13.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.14.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Narcolepsy Therapeutics Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.6.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.7.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.8.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.9.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.10.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Narcolepsy Therapeutics Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.6.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.7.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.8.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.9.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.10.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.11.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.12.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Narcolepsy Therapeutics Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Teva Pharmaceutical Industries Ltd.
    • 10.2.2. Avadel Pharmaceuticals
    • 10.2.3. Jazz Pharmaceuticals, Inc.
    • 10.2.4. Takeda Pharmaceutical Company
    • 10.2.5. Harmony Biosciences
    • 10.2.6. Novartis AG
    • 10.2.7. Rhodes Pharmaceuticals L.P.
    • 10.2.8. Axsome Therapeutics, Inc.
    • 10.2.9. Janssen Global Services, LLC
    • 10.2.10. Ligand Pharmaceuticals Incorporated
    • 10.2.11. Shionogi Inc.
    • 10.2.12. Eli Lilly and Company
    • 10.2.13. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Narcolepsy Therapeutics Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Narcolepsy Therapeutics Market, by Type 2018-2030 (USD Million)
  • TABLE Narcolepsy Therapeutics Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Narcolepsy Therapeutics Market, by Product 2018-2030 (USD Million)
  • TABLE Narcolepsy Therapeutics Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Narcolepsy Therapeutics Market, by End-User 2018-2030 (USD Million)
  • TABLE Narcolepsy Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Narcolepsy Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)